Severine Kako
Neurology · Portland, ORNPI 1629605944
Payments from drug & device makers
What this record shows
This record is dominated by grants: $30,000 of the $35,992 with a category attached, or 83.4%. Medtronic accounts for 65.4% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2024 at $32,518 and has fallen 92.4% since, to $2,466 in 2025. Among neurology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $302.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$24K
- Boston Scientific$11K
- E.r. Squibb & Sons, L.L.C.$338
- EMD Serono, Inc.$282
- AstraZeneca$183
- Novartis$160
- plus $847 from 18 others
What the payments were for
- Grants$30,00083%
- Travel & lodging$2,8578%
- Food & beverage$3,1349%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 42 | $23,530 |
| Boston Scientific | 5 | $10,651 |
| E.r. Squibb & Sons, L.L.C. | 3 | $338 |
| EMD Serono, Inc. | 19 | $282 |
| AstraZeneca(2 entities) | 11 | $183 |
| Novartis | 9 | $160 |
| Revance Therapeutics, Inc. | 1 | $121 |
| Abbott | 1 | $102 |
| UCB, Inc. | 4 | $94 |
| Biogen | 1 | $93 |
| Averitas Pharma Inc. | 4 | $92 |
| Pfizer | 4 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 2 | $44 |
| Eisai Inc. | 2 | $36 |
| Merz Pharmaceuticals, LLC | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
| Sanofi | 1 | $18 |
| Lilly USA, LLC | 1 | $17 |
| Jazz Pharmaceuticals Inc. | 1 | $17 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Bristol Myers Squibb | 1 | $17 |
| Amgen | 1 | $16 |
| AbbVie | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$35,992 in reported general payments places this provider in the 90th percentile of 228 neurology providers in Oregon.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Carbidopa-LevodopaCarbidopa/Levodopa | 102 | $2,819 |
| Primidone | 33 | $1,248 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 26 | $758 |
| Baclofen | 16 | $635 |
| Gabapentin | 14 | $392 |
| Donepezil Hcl | 15 | $131 |
Paid to pharmacies, not to this prescriber.
Other neurology in Portland
- Kyle SmootPortland$932K
- Chafic KaramPortland$727K
- Herbert KrobPortland$416K
- Stanley CohanPortland$334K
- Matthew BrodskyPortland$123K
- Delaram SafarpourPortland$77K
- Kiren Kresa-ReahlPortland$71K
- Nizar ChahinPortland$57K
- Jeffrey KayePortland$54K
- Michelle CameronPortland$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.